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Background: Few controlled trials have assessed the efficacy of spinal manipulative therapy (SMT) for thoracic
spine pain. No high quality trials have been performed to test the efficacy and effectiveness of Graston Technique®
(GT), an instrument-assisted soft tissue therapy. The objective of this trial was to determine the efficacy of SMT and
GT compared to sham therapy for the treatment of non-specific thoracic spine pain.
Methods: People with non-specific thoracic pain were randomly allocated to one of three groups: SMT, GT, or a
placebo (de-tuned ultrasound). Each participant received up to 10 supervised treatment sessions at Murdoch
University chiropractic student clinic over a 4 week period. The participants and treatment providers were not
blinded to the treatment allocation as it was clear which therapy they were receiving, however outcome assessors
were blinded and we attempted to blind the participants allocated to the placebo group. Treatment outcomes
were measured at baseline, 1 week, and at one, three, six and 12 months. Primary outcome measures included a
modified Oswestry Disability Index, and the Visual Analogue Scale (VAS). Treatment effects were estimated with
intention to treat analysis and linear mixed models.
Results: One hundred and forty three participants were randomly allocated to the three groups (SMT = 36, GT = 63
and Placebo = 44). Baseline data for the three groups did not show any meaningful differences. Results of the
intention to treat analyses revealed no time by group interactions, indicating no statistically significant between-
group differences in pain or disability at 1 week, 1 month, 3 months, 6 months, or 12 months. There were
significant main effects of time (p < 0.01) indicating improvements in pain and disability from baseline among all
participants regardless of intervention. No significant adverse events were reported.
Conclusion: This study indicates that there is no difference in outcome at any time point for pain or disability
when comparing SMT, Graston Technique® or sham therapy for thoracic spine pain, however all groups improved
with time. These results constitute the first from a fully powered randomised controlled trial comparing SMT,
Graston technique® and a placebo.
Trial Registration: This trial was registered with the Australia and New Zealand Clinical Trials Registry on the 7th
February, 2008. Trial number: ACTRN12608000070336
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Thoracic spinal pain is common with most occupational
groups having 1-year prevalence around 30 % [1]. Com-
monly used treatment options for non-specific thoracic
spine pain include manual therapies such as massage,
mobilisation, and spinal manipulative therapy (SMT) [2],
however there are no high quality studies evaluating
these modalities. To date there are only two published
randomised controlled trials whose primary aim was to
assess the effectiveness of SMT on thoracic spinal pain
[3, 4]. In the first study by Schiller [3] the author con-
ducted a small study of 30 patients with ‘mechanical
thoracic spine pain’ where SMT was compared to a
sham comprising non-functional ultrasound. While pa-
tients in the SMT group reported lower pain intensity
and greater lateral flexion range of motion immediately
following the 2 to 3 week treatment period, there were
no differences after 1 month. Concurrently, there were
no between-group differences in McGill Pain and
Oswestry Disability scores at any point of the trial.
In the second study by Lethola et al. [4], thoracic
spinal manipulation and needle acupuncture led to simi-
lar outcomes as placebo electrotherapy in reducing pain
in female patients with recent-onset mechanical thoracic
spinal pain. This three arm study randomised 114 fe-
males aged 20–60 with thoracic spine pain (≤3-month
duration) between the third and eighth thoracic verte-
brae to receive a high-velocity thrust spinal manipula-
tion, needle acupuncture, or placebo electrotherapy with
intermittent suction. All interventions were provided by
the same physiotherapist 4 times per week for 3 weeks.
The study results showed small differences in pain reduc-
tion favouring manipulation 1-week post-intervention.
However, these differences were not clinically important.
A third study was identified in a systematic review
[5] of non-invasive interventions for musculoskeletal
chest wall pain and thoracic pain, in this study [6]
Stochkendahl et al. used a secondary outcome meas-
ure of severity of thoracic pain associated with their
primary interest of acute chest wall pain. They studied
115 patients aged 18–75 years presenting to an emergency
cardiology department in Denmark. Fifty-nine patients
were randomised to receive a multimodal program of care
provided by a chiropractor (up to 10 visits/4 weeks)
including manipulation to the cervical and/or thoracic
spine, combined with any or all of the following: joint
mobilization, soft tissue therapy, stretching, stabilizing
or strengthening exercises, heat or cold, and advice.
There were 56 in the control group who received a
single 15 min session of education provided by a
chiropractor, which included reassurance and advice
promoting self-management and individualized instruction
on posture and home exercises to increase spinal move-
ment or muscle stretch. While this study’s primaryoutcome was acute chest pain, data on thoracic pain was
obtained and there were no differences between the groups
at 4, 12 and 52 weeks.
The results of the trials above are similar to those
found in systematic reviews of manual therapy for neck
pain [7] and low back pain [8, 9].
For the purposes of this study we chose to evaluate
SMT, Graston technique® (GT) [10] and a placebo treat-
ment. The reasons for these choices are that SMT is a
commonly used treatment worldwide [11] and GT is a
popular soft-tissue technique in the United States and
becoming more popular in other developed countries
[12, 13]. GT is an instrument-assisted soft-tissue therapy
involving the use of hand-held stainless steel instru-
ments. The promoters of the GT [10] claim that the in-
struments resonate in the clinician’s hands allowing the
clinician to isolate soft-tissue “adhesions and restrictions”,
and treat them precisely. While there are two preliminary
studies that show a) an increased blood flow with the use
of GT [12] and b) improvements in shoulder ranges of
motion among baseball players with its application [13]
we are not aware of any high level evidence to support
claims or the effectiveness of GT for spinal pain.
Given the lack of scientific evidence for the use of this
modality and its apparent popularity for spinal pain a
high quality trial was deemed necessary to determine
efficacy.
Accordingly, we conducted a study to determine the
efficacy of SMT and GT compared to sham therapy for
the treatment of non-specific thoracic pain.
Methods
The full protocol of this study has been published in free
full text format elsewhere [14]. In summary, the study
was a three-arm randomised, placebo-controlled trial,
conducted between March 2008 and July 2009, compar-
ing two treatment modalities to a sham intervention for
people with acute or sub-acute thoracic spine pain. The
therapy arms consisted of SMT and GT and the sham
was non-functional ultrasound. Ethics approval was
granted by Murdoch University Human Research and
Ethics Committee (2007/274).
Study sample and participant enrolment
The study was conducted at the Murdoch University
Chiropractic student clinic in Perth, Western Australia.
Participants were recruited using advertisements posted
around the Murdoch University Campus, on local com-
munity boards and in newspapers.
Potential participants were screened with a detailed
history and physical examination by a research assistant
who applied the inclusion and exclusion criteria. Eligible
participants were invited to enter the trial and asked to
read and sign a consent form.
Table 1 Definition of non-specific thoracic spine pain [15]
- Midline back pain - for the purposes of this trial, the pain will be
bound by the lateral margins of the thorax laterally and the
trapezium superiorly
- Non dermatomal referred pain difficult to localise
- No signs of nerve root tension
- No major neurological deficit
- Pain with compression over the thoracic spine into spine extension
- Reduced range of motion
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People were included if they met the following criteria:
1. Age 18 years or older with non-specific thoracic
spine pain of any duration, which was defined as
pain in the region from T1 to T12 (Fig. 1) and
complied with the descriptive classification by
Triano et al. [15] (Table 1).
2. A Visual Analogue Score (VAS) pain score of at least
2 out of 10 and an Oswestry Disability Index (ODI)
score of greater than 15 % at baseline [16, 17].
Exclusion criteria
People were excluded if they met any of the following
criteria:
1. Had a contraindication to manual therapy including
osteoporosis, thoracic fracture, spinal infection,
neoplastic disorders, spondyloarthropathy, and
clinical examination suggestive of frank disc
herniation or generalised infection such as
influenza.
2. Had a contraindication to Graston technique
including neoplastic disorders, kidney infection,
anticoagulant medication, rheumatoid arthritis,
uncontrolled hypertension, thoracic fracture,
osteomyelitis or generalised infection.Fig. 1 Shaded area defining the region of the thoracic spine where
pain could be experienced for inclusion into the trial3. Had somatic conditions found on examination to
refer pain to the thoracic spine from outside the
defined area (including cervical zygapophyseal joints,
muscles and discs).
4. Had an active history of visceral conditions referring
pain to the thoracic spine including myocardial
ischaemia, dissecting thoracic aortic aneurysm,
peptic ulcer, acute cholecystitis, pancreatitis, renal
colic, acute pyelonephritis
5. Had a current substance abuse problem.
6. Was not fluent and/or literate in the English language.
7. Was currently receiving care for thoracic pain from
any other healthcare provider.
8. Could not commit to the full study protocol.
9. Was currently seeking compensation or had
commenced litigation for thoracic spine pain.
Treatment allocation
Randomisation occurred directly after baseline measures
were taken, after the participant had been screened for
inclusion and informed consent provided. An online
randomisation site, Research Randomiser [18], was used
to generate treatment allocation. This online randomisa-
tion module is a web browser application that supports
online randomisation of patients into healthcare trials. 150
random basis sequences without blocs were generated,
and then placed in sequentially numbered, opaque, sealed
envelopes and stored in a sealed box. As each participant
entered the trial the next consecutive opaque, sealed enve-
lope was given to the treating student and supervising
clinician by the research assistant.
Interventions and treatment
Participants were randomised to one of three treatment
arms as follows:
1. Chiropractic group: a series of high velocity low
amplitude chiropractic manual adjustments (SMT)
to the thoracic spine were administered by a
registered chiropractor or a final year chiropractic
student under the direct supervision of a registered
chiropractor. The thrust direction was at the
discretion of the treating chiropractor or student.
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was administered by final year chiropractic
students who were certified in module one of the
Graston Technique, under the direct supervision
of a registered chiropractor who attended each
consultation and in addition placed their hands
on the anatomical regions involved;
3. Placebo group: participants received a session of
de-tuned ultrasound administered by a final year
chiropractic student, under the direct supervision
of a registered chiropractor who attended each
consultation and also placed their hands on the
anatomical regions involved.
The reason for the random placement of hand near
the painful area by the chiropractors for participants in
groups 2 and 3 was designed to mitigate any lack of
confidence in a student intern interaction and to provide
a hands-on component to the therapy and make it more
equivalent to the group 1 experience.
All treating students and chiropractors were briefed
on the administration of the study and trained to show
the same enthusiasm for all three treatment modalities.
To minimise potential for attention effects, we standar-
dised the delivery of therapy such that all sessions lasted
10–15 min, irrespective of treatment group. The admin-
istration of the various modalities and monitoring of
progress is described in detail elsewhere [14] however,
we aimed to administer 10 treatments of each of the
“therapies” over 3–4 weeks to each participant.
Change in inclusion criteria from the protocol
Initially, eligible participants were people with non-
specific thoracic pain of less than 3 months duration.
However, recruitment was slow so this was amended to
also include participants with any duration of pain.
Outcome measures and baseline data
Treatment outcomes comprised self-reported pain inten-
sity with a 100 mm Visual Analogue Scale (VAS) and
pain-related disability measured with a version of the
Oswestry Disability Index (ODI) modified for patients
with thoracic spine pain. These instruments are dis-
cussed in detail in the study protocol [14]. Outcomes
were administered at baseline, 1 week after treatment
commenced, upon completion of the 4-week interven-
tion period and at three, six and 12 months.
A variation to the published protocol occurred with the
decision to not obtain some baseline measures of race/eth-
nicity, education, household income, marital status, current
employment status and general health status using the
Short-Form Health Survey (SF-36). This was partly due to
anticipated participant fatigue and that these extra baseline
questions would likely put them off participating in the trial.Adverse effects
Participants were provided with a list of potential adverse
effects in an information letter prior to giving consent.
Participants recorded information about adverse events in
a log book.
Blinding
The two outcome measures were self-administered instru-
ments. Participants were given blank questionnaires in a
package by a research assistant following their first treat-
ment. Participants were instructed to complete the instru-
ments at each assessment time point. After completion of
the forms the participant posted them back to the
Murdoch University Chiropractic Clinic. Research assis-
tants remained blind to the outcome data for the entire
study period. The participants and treatment providers
were not blinded to the treatment allocation as it was clear
that the groups were receiving different treatments. Partic-
ipants in the placebo group were blinded to their placebo
allocation until follow-up was complete at 12 months. Par-
ticipants were surveyed for the adequacy of the placebo
blinding at the end of the study.
Sample size calculations
To calculate the sample size, we used the means of 23.9,
18.9 and 13.9 and assumed a standard deviation of 12.1 of
the ODI derived in a study by Hoiriis et al. [19] in a simi-
lar chiropractic teaching setting. The clinical effect size
used for the ODI was 10 % [17], alpha was set at .05.
Recruiting 30 participants per group was calculated to
provide 80 % power to identify between-group differences
this large or larger. Sample size calculations using the VAS
from the previous study resulted in a smaller n value for
each group, therefore the ODI was used. We used 30 as a
minimum requirement for each group.
Data analysis
A researcher blinded to group allocation analysed the
data. Statistical analyses were performed using IBM SPSS
Statistics v21. The statistical analysis varied from the pub-
lished protocol in the following way. Treatment effects
were estimated using separate, random-intercept linear
mixed models for each outcome variable. Time (1 week,
4 weeks, 3 months, 6 months, and 12 months) and treat-
ment group (placebo, MT, Graston) were modelled as
fixed effects. The hypothesis of interest was the time by
group interaction which we further examined with pair-
wise comparisons of the estimated marginal means. We
included the baseline outcome score as a covariate in each
model. Consistent with the intention to treat principle, the
linear mixed models estimated values for missing data
based on available scores; therefore all participants rando-
mised to a treatment group were included in the analyses
of clinical outcomes. Alpha level was 0.05 for all analyses.
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The participant flow through the trial is presented in Fig. 2;
376 people responded to advertisements and after screen-
ing 144 patients were considered eligible for the study and
were randomised to a study group. One participant was
omitted from the study and their data not included in the
analysis; this participant was excluded after beingFig. 2 Flow chart of participantsincorrectly randomised leaving 143 participants. It was
discovered that the randomisation sequence for this one
participant was interrupted and the participant was incor-
rectly allocated by a clinic supervisor holding an envelope
up to a bright light in advance of allocation. Demographic
and clinical information at baseline is described in Table 2.
There were no important differences in prognostic
Table 2 Baseline data for the entire sample and the three treatment groups
Variable All (N = 143) SMT (N = 36) Graston (N = 63) Placebo (N = 44)
Age (years) 45.8 (13.7) 44.4 (13.0) 44.8 (14.3) 48.5 (13.0)
Sex (% Male) 53.2 55.6 50.2 54.6
Pain (0-10 VAS) 5.6 (2.0) 5.5 (2.0) 5.7 (2.1) 5.5 (2.0)
Disability (0-100 ODI) 28.5 (10.4) 27.2 (10.2) 29.6 (11.1) 28.1 (9.9)
Pain duration (years) 9.2 (12.0) 9.0 (16.0) 8.2 (11.0) 10.9 (9.4)
Values are mean (standard deviation) unless otherwise indicated
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recruitment strategy resulted in an overwhelming number
of participants with long standing pain.
Of the total enrolled participants, there was a similar
loss to follow up from each treatment group. Based
upon results in Fig. 2, at 12 months the numbers lost to
follow-up between groups compared to baseline, was
SMT (28 %), Graston (45 %) and Placebo (41 %). Drop
outs were unable to be contacted to determine the rea-
son for loss to follow up.
Table 3 shows the pain (VAS) and disability (ODI)
scores for the three treatment groups from baseline
through all time points of follow up.
Analysis demonstrates that there was no difference
between the treatment groups for pain (Fig. 3) or disabil-
ity (Fig. 4) at any time point.
Results of the intention to treat analyses revealed no
time by group interactions, indicating no significant
between-group differences in pain or disability at 1 week,
4 weeks, 3 months, 6 months, or 12 months (Table 3).
There were significant main effects of time (p < 0.01) for
both pain and disability indicating improvements in painTable 3 Results of the intention-to-treat analysis comparing clinical
Mean (SD) for each group
Graston SMT Placebo
Disability (0-100)*
Baseline 29.6 (11.0) 27.2 (10.0) 28.1 (9.8)
1 week 22.6 (11.8) 22.3 (10.0) 23.7 (12.1)
1 month 18.1 (12.0) 19.8 (11.7) 21.5 (12.3)
3 months 16.2 (13.1) 21.0 (14.3) 18.7 (15.0)
6 months 16.2 (13.1) 18.2 (14.2) 16.9 (14.1)
12 months 16.3 (13.5) 21.2 (16.0) 16.1 (16.3)
Pain intensity (0-10)†
Baseline 5.7 (2.1) 5.5 (2.0) 5.5 (1.9)
1 week 4.7 (1.9) 5.1 (2.0) 4.7 (1.8)
1 month 3.4 (1.9) 4.3 (2.0) 4.2 (2.4)
3 months 3.2 (2.6) 4.0 (2.2) 3.5 (2.3)
6 months 3.5 (2.5) 3.6 (2.2) 3.6 (2.5)
12 months 3.2 (2.3) 3.8 (2.4) 3.3 (2.5)
*Time by treatment group interaction p = 0.24
†Time by treatment group interaction p = 0.58and disability from baseline among all participants
(Table 3).
No significant adverse events were notified in this trial,
however one participant reported increased pain after
the placebo therapy. The participant dropped out of the
study at this point and was lost to follow up.
Blinding
Participants in the placebo group were asked at
12 months about the group to which they were allocated
SMT, “other physical therapy” or just “other”. Only 8
participants responded to the question, 5 of whom
thought they were in the SMT group and 3 in the “Other
PT group”, none thought they were allocated to the
“Other group” i.e. the placebo group.
Discussion
Our study indicates that there is no difference in out-
come at any time point for pain or disability when com-
paring SMT, Graston technique or placebo therapy for
long standing thoracic spine pain, however all groups
improved with time. These results constitute the firstoutcomes between treatment groups
Adjusted mean difference between groups (95 % CI)
Graston vs MT Graston vs placebo SMT vs placebo
- - -
-0.58 (-4.7,3.6) -1.9 (-5.8,2.0) -1.3 (-5.8,2.0)
-3.4 (-7.7, 0.9) -4.5 (-8.6, -0.4) -1.1 (-5.7, 3.6)
-4.6 (-9.5, 0.4) -2.1 (-7.0, 2.8) 2.5 (-2.9, 7.9)
-1.9 (-6.9, 2.9) -0.4 (-4.9, 4.2) 1.6 (-3.7, 6.9)
-4.8 (-10.5, 0.9) -1.2 (-6.8, 4.4) 3.6 (-2.5, 9.7)
- - -
-0.3 (-1.2, 0.5) 0.1 (-0.7, 0.8) 0.4 (-0.5, 1.2)
-1.0 (-1.9, -0.2) -0.9 (-1.7, -0.1) 0.1 (-0.8, 1.0)
-0.8 (-1.8, 0.1) -0.3 (-1.3, 0.6) 0.5 (-0.5, 1.5)
-0.4 (-1.4, 0.7) -0.2 (-1.2, 0.8) 0.2 (-1.0, 1.3)
-0.8 (-1.9, 0.3) -0.4 (-1.5, 0.7) 0.4 (-0.8, 1.6)

























Fig. 3 Mean group visual analogue scale pain scores over time with 95 % confidence intervals
Crothers et al. Chiropractic & Manual Therapies  (2016) 24:16 Page 7 of 9from an adequately powered randomised controlled trial
comparing spinal manipulation, Graston technique and
a placebo. It appears that our findings differ from the
one other randomised trial [3] that reported SMT to be
superior to sham for thoracic spine pain reduction, how-
ever that trial was inadequately powered and a Type II
error was likely.
The results of our study are similar to those published
for manipulation for low back pain [8] and for neck pain
[7] where comparisons of manipulation to other modal-
ities show only small treatment effects. The anatomy
and biomechanics of the lumbar and cervical spines dif-
fer to that of the thoracic spine in that, among other
things, the thoracic vertebrae are bound by ribs. How-
ever, our results suggest that these anatomical differ-
ences have not made any difference to clinical outcome
after manual therapy is applied.
The strengths of this study lie in its randomised design
and the inclusion of a sham or placebo arm for compari-
son of the active therapies involved. Another strength
was the power of the study which was pre-determined
and met by an initially adequate sample size.
Limitations to our study were the use of a modified
Oswestry Disability Index (ODI) for the thoracic spine.
We modified the original ODI [20] by replacing the

















Fig. 4 Mean group Oswestry disability scores over time with 95 % confidenthis to the commonly used version where sexual difficul-
ties had been removed. Otherwise the ODI was left in-
tact. However it should be noted that the ODI was
constructed for low back pain disability and as such may
not be valid for mid back pain disability. Nevertheless
there were no validated instruments to specifically meas-
ure thoracic spine pain related disability. Further validity
studies should be undertaken to test this instrument for
use in measuring thoracic spine disability. Even though
dropout rates were similar between groups the lack of
information regarding reasons for drop outs is also a
limitation. This lack of information was caused by logis-
tics and funding constraints that prevented us employing
the human resources necessary to follow participants up.
In addition, while we recorded the number of drop outs
per group we did not record if a participant was pain
free after less than 10 consultations and as such we are
unable to report the average number of treatments per
group or their range. Because of the size of the drop out
rate treatment effect estimates beyond 3 months should
be interpreted with caution. One participant was omitted
from the study because they were incorrectly rando-
mised and their data not included in the analysis when it
was discovered that a clinic supervisor held an envelope
up to a bright light in advance of allocation. This oc-
curred despite briefing all clinical supervisors about the3 months 6 months 1 year
ShamMT
ce intervals
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breach the randomisation sequence cards were wrapped
in aluminium foil and placed back into their envelopes
and the supervisor was counselled.
Another possible limitation is the use of final year
chiropractic interns to deliver the SMT and Graston
therapy whose therapy outcomes may differ from more
experienced clinicians. We did not record whether the
intern or the practitioner delivered the treatment but it
was under the supervision of the practitioner and had to
be performed to their satisfaction. This was in accord
with the published protocol. In addition, there is some
evidence that therapist-related factors of increased ex-
perience and specialty certification status do not result
in an improvement in patients’ disability associated with
back pain [21]. All students had been certified in Stage I
Graston therapy use by a certified Graston therapist.
Regarding blinding of the placebo group we were unable
to draw any conclusion on its success given the poor
response to the question.
A final limitation occurred in the disproportionate
numbers randomly allocated to the three groups, i.e. 36,
63 and 44. This imbalance resulted from the use of
simple randomisation wherein each participant had an
equal likelihood of being assigned to the groups.
However, by chance an unequal number of individuals
were assigned to each arm of the study and this may
have adversely affected an optimum level of statistical
power. Block randomization is a commonly used
technique in clinical trial design to reduce bias and
achieve balance in the allocation of participants to
treatment arms, especially when the sample size is
small [22]. In hindsight we should have used block
randomisation as this would have resulted in equal
group sizes.
The clinical implications and generalisability of this
study are limited because while the results suggest that
all of the methods tested provided benefit for chronic
mid back pain this benefit included the placebo/sham
arm. This apparent lack of effect may be due, at least in
part, to the tendency to treat non-specific mid-back pain
as a homogenous condition, rather than a heterogeneous
collection of as yet undefined but differing conditions,
some of which might respond and others that do not
respond to a particular therapy. Research to identify
diagnostic subsets within non-specific mid-back pain
may be worthy and if successful, individual therapies
such as manual therapy or Graston technique may be
better directed.
Conclusion
This study indicates that there is no difference in out-
come at any time point for pain or disability when com-
paring spinal manipulative therapy, Graston Technique®or sham therapy for non-specific thoracic spine pain,
however all groups improved with time. These results
constitute the first from a fully powered randomised
controlled trial comparing spinal manipulative therapy,
Graston technique® and a placebo.
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